Skip to main content
Clinical Trials/EUCTR2018-002876-41-FR
EUCTR2018-002876-41-FR
Active, not recruiting
Phase 1

Assesment of Propofol sedation during intra tracheal surfactant administration by the LISA method (Less Invasive Surfactant Administration) - PROLISA

CHU Grenoble-Alpes0 sites542 target enrollmentAugust 8, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CHU Grenoble-Alpes
Enrollment
542
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 8, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
CHU Grenoble-Alpes

Eligibility Criteria

Inclusion Criteria

  • \- Preterm Infants \< 32 wGA
  • \- Presenting a RDS
  • in the first 48 hours of life
  • treated by CPAP
  • requiring surfactant :
  • if 28 \- 31 SA : FiO2 \=30% for a duration \= 10mn
  • if \<28 SA FIO2 \=25% for a duration \=10mn
  • To obtain a SaO2 between \=88 and \= 95%
  • \- Available Intra\-Venous line
  • \- Covered by French Social Security

Exclusion Criteria

  • \- Congenital and/or major malformations
  • \- FIO2\> 60%
  • \- Silverman score\> at 6
  • \- Low Blood Pressure with 2 successive measurements (Mean \< Gestational Age expressed in Weeks of Gestation) persisting after one volume expansion
  • \- Use of inotropic medication to maintain normal blood pressure.
  • \- Use of sedative or analgesic drugs (except paracetamol and ibuprofen) in the previous 24h

Outcomes

Primary Outcomes

Not specified

Similar Trials